The role of chemical mediators in eosinophil infiltration in allergic rhinitis in mice

International Immunopharmacology

Volumn 3, Issue 4, 2003, Pages 469-473

  Kayasuga, Ryoji ^a   Iba, Yoshinori ^a   Hossen, Maria Alejandra ^a   Watanabe, Takeshi ^b   Kamei, Chiaki ^a  

^a OKAYAMA UNIVERSITY   (Japan)

^b KYUSHU UNIVERSITY   (Japan)

Author keywords

Histamine H1 receptor deficient mice; Histopathological changes; Leukotriene; Nasal eosinophilia; Thromboxane A2

Indexed keywords

CETIRIZINE; EPINASTINE; HISTAMINE H1 RECEPTOR; HISTAMINE H1 RECEPTOR ANTAGONIST; LEUKOTRIENE RECEPTOR BLOCKING AGENT; OVALBUMIN; RAMATROBAN; THROMBOXANE A2 RECEPTOR BLOCKING AGENT; ZAFIRLUKAST;

ALLERGIC RHINITIS; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; EDEMA; EOSINOPHIL; HISTOLOGY; IMMUNIZATION; MEDIATOR; MOUSE; NONHUMAN; NOSE MUCOSA; PRIORITY JOURNAL; SENSITIZATION; WILD TYPE;

EID: 0037389927     PISSN: 15675769     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1567-5769(02)00254-0     Document Type: Article

References (20)

1. Jankowski R., Persoons M., Foliguet B., Coffinet L., Thomas C.et al. Eosinophil count in nasal secretions of subjects with and without nasal symptoms. Rhinology. 38:2000;23-32.
2. Wang D.-Y., Clement P. Pathogenic mechanisms underlying the clinical symptoms of allergic rhinitis. Am. J. Rhinol. 14:2000;325-333.
3. Gleich G.J., Loegering D.A. Immunobiology of eosinophils. Annu. Rev. Immunol. 2:1984;429-459.
4. 4 in an experimental allergic rhinitis model: contribution of dilated mucosal blood vessels. Jpn. J. Pharmacol. 86:2001;170-182.
5. Misawa M., Iwamura S. Platelet-activating factor (PAF)-induced rhinitis and involvement of PAF in allergic rhinitis in guinea pigs. Jpn. J. Pharmacol. 54:1990;217-226.
6. Martin L.B., Kita H., Leiferman K.M., Gleich G.J. Eosinophils in allergy: role in disease, degranulation, and cytokines. Int. Arch. Allergy Immunol. 109:1996;207-215.
7. Asako H., Kurose I., Wolf R., DeFrees S., Zheng Z.-L.et al. Role of H1 receptors and P-selectin in histamine-induced leukocyte rolling and adhesion in postcapillary venules. J. Clin. Invest. 93:1994;1508-1515.
8. Kubes P., Kanwar S. Histamine induces leukocyte rolling in post-capillary venules. J. Immunol. 152:1994;3570-3577.
9. 4 effects on human eosinophil and neutrophil motility in vitro. J. Leukoc. Biol. 55:1994;183-191.
10. 1 receptors. Proc. Natl. Acad. Sci. U. S. A. 93:1996;13316-13320.
11. 1 receptors. Eur. J. Pharmacol. 449:2002;287-291.
12. 2 receptor antagonist (Bay u 3405) on nasal symptoms after antigen challenge in sensitized guinea pigs. Int. Arch. Allergy Immunol. 109:1996;161-166.
13. Takeda K., Hamelmann E., Joetham A., Shultz L.D., Larsen G.L.et al. Development of eosinophilic airway inflammation and airway hyperresponsiveness in mast cell-deficient mice. J. Exp. Med. 186:1997;449-454.
14. Van de Rijn M., Mehlhop P.D., Judkins A., Rothenberg M.E., Luster A.D.et al. A murine model of allergic rhinitis: studies on the role of IgE in pathogenesis and analysis of the eosinophil influx elicited by allergen and eotaxin. J. Allergy Clin. Immunol. 102:1998;65-74.
15. Fadel R., Herpin-Richard N., Rihoux J.P., Henocq E. Inhibitory effect of cetirizine 2HCL on eosinophil migration in vivo. Clin. Allergy. 17:1987;373-379.
16. Ciprandi G., Buscaglia S., Pesce G., Passalacqua G., Rihoux J.P.et al. Cetirizine reduces inflammatory cell recruitment and ICAM-1 (or CD54) expression on conjunctival epithelium in both early- and late-phase reactions after allergen-specific challenge. J. Allergy Clin. Immunol. 95:1995;612-621.
17. 2 inhibitors on allergic pulmonary inflammation in mice. Eur. Respir. J. 11:1998;624-629.
18. Muñoz N.M., Douglas I., Mayer D., Herrnreiter A., Zhu X.et al. Eosinophil chemotaxis inhibited by 5-lipoxygenase blockade and leukotriene receptor antagonism. Am. J. Respir. Crit. Care Med. 155:1997;1398-1403.
19. 4 receptor antagonist, pranlukast, or an interleukin-5 monoclonal antibody. Am. J. Respir. Crit. Care Med. 154:1996;850-857.
20. Krell R.D., Dehaas C.J., Lengel D.J., Kusner E.J., Williams J.C.et al. Preclinical exploration of the potential antiinflammatory properties of the peptide leukotriene antagonist ICI 204,219 (Accolate). Ann. N. Y. Acad. Sci. 744:1994;289-298.